Cardiovascular Drugs and Therapy

, Volume 21, Issue 1, pp 47–53 | Cite as

Anti-arrhythmic Effects of I Na, I Kr, and Combined I KrI CaL Blockade in an Experimental Model of Acute Stretch-Related Atrial Fibrillation

  • J. Kalifa
  • M. Bernard
  • B. Gout
  • A. Bril
  • D. Cozma
  • P. Laurent
  • T. Chalvidan
  • J. C. Deharo
  • P. Djiane
  • P. Cozzone
  • J. M. Maixent



Atrial dilatation is commonly associated with atrial fibrillation (AF), but the electrophysiological mechanisms and the implications for anti-arrhythmic therapy are poorly understood. In a model of acute stretch-related AF in isolated rabbit hearts, we evaluated the electrophysiological effects of three different anti-arrhythmic drugs: dofetilide, flecainide and BRL-32872 (associating I Kr and I CaL blocking properties).


After 30 min of sustained stretch-related AF, we perfused BRL 10–7 M, BRL 3.10–7 M, BRL 10–6 M, flecainide 2.4 10–6 M and dofetilide 10–7 M and iteratively measured atrial effective refractory periods (ERPs), AF inducibility and AF cycle length (AFCL) 15, 30 and 60 min after drug perfusion, respectively.


After a significant shortening of the ERPs by acute atrial stretch in the five groups individually (p < 0.001, stretch vs baseline for each group individually), drug perfusion led to a strong lengthening of AFCL, a very significant prolongation of ERPs (p < 0.001 vs stretch) and a reduction of AF inducibility (p < 0.01 vs control group) for each of the five experimental groups. The relative ERP increase was comparable in all groups, whereas a significantly lower AF inducibility was observed in the BRL 10–6 M group (p < 0.05 vs other BRL concentrations).


In a model of acute stretch-related AF, dofetilide, flecainide and BRL-32872 terminated AF and prevented its immediate reinduction after having comparatively prolonged AFCL and ERPs. These comparative results suggest that those drugs are equally efficacious, albeit with different mechanisms, in the setting of acute atrial stretch.

Key words

atrial fibrillation atrial stretch anti-arrhythmic drugs 



Smithkline Beecham supported this work. Jérôme Kalifa was supported by the ADEREM (Marseilles).


  1. 1.
    Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998;82:2N–9.PubMedCrossRefGoogle Scholar
  2. 2.
    Satoh T, Zipes DP. Unequal atrial stretch in dogs increases dispersion of refractoriness conducive to developing atrial fibrillation. J Cardiovasc Electrophysiol 1996;7:833–42.PubMedCrossRefGoogle Scholar
  3. 3.
    Ravelli F, Allessie M. Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated Langendorff-perfused rabbit heart. Circulation 1997;96:1686–95.PubMedGoogle Scholar
  4. 4.
    Bode F, Katchman A, Woosley RL, Franz MR. Gadolinium decreases stretch-induced vulnerability to atrial fibrillation. Circulation 2000;101:2200–5.PubMedGoogle Scholar
  5. 5.
    Verheule S, Wilson E, Banthia S, Everett TH 4th, Shanbhag S, Sih HJ, et al. Direction-dependent conduction abnormalities in a canine model of atrial fibrillation due to chronic atrial dilatation. Am J Physiol Heart Circ Physiol 2004;287:H634–44.PubMedCrossRefGoogle Scholar
  6. 6.
    Verheule S, Wilson E, Everett T 4th, Shanbhag S, Golden C, Olgin J. Alterations in atrial electrophysiology and tissue structure in a canine model of chronic atrial dilatation due to mitral regurgitation. Circulation 2003;107:2615–22.PubMedGoogle Scholar
  7. 7.
    Sih HJ, Zipes DP, Berbari EJ, Adams DE, Olgin JE. Differences in organization between acute and chronic atrial fibrillation in dogs. J Am Coll Cardiol 2000;36:924–31.PubMedCrossRefGoogle Scholar
  8. 8.
    Flegel KM. When atrial fibrillation occurs with pulmonary embolism, is it the chicken or the egg? CMAJ 1999;160:1181–2.PubMedGoogle Scholar
  9. 9.
    Klein HO, Bakst A, Kaplinsky E. Pulmonary embolism and atrial fibrillation. Am J Cardiol 1988;61:498–9.PubMedCrossRefGoogle Scholar
  10. 10.
    O’Toole L, McLean KA, Channer KS. Pulmonary embolism presenting with atrial fibrillation. Lancet 1993;342:1050.PubMedCrossRefGoogle Scholar
  11. 11.
    Kalifa J, Jalife J, Zaitsev AV, Bagwe S, Warren M, Moreno J, et al. Intra-atrial pressure increases rate and organization of waves emanating from the superior pulmonary veins during atrial fibrillation. Circulation 2003;108:668–71.PubMedCrossRefGoogle Scholar
  12. 12.
    Kim D, Fu C. Activation of a nonselective cation channel by swelling in atrial cells. J Membr Biol 1993;135:27–37.PubMedGoogle Scholar
  13. 13.
    Kim D. Novel cation-selective mechanosensitive ion channel in the atrial cell membrane. Circ Res 1993;72:225–31.PubMedGoogle Scholar
  14. 14.
    Kim D. A mechanosensitive K+ channel in heart cells. Activation by arachidonic acid. J Gen Physiol 1992;100:1021–40.PubMedCrossRefGoogle Scholar
  15. 15.
    Bode F, Sachs F, Franz MR. Tarantula peptide inhibits atrial fibrillation. Nature 2001;409:35–6.PubMedCrossRefGoogle Scholar
  16. 16.
    Zarse M, Stellbrink C, Athanatou E, Robert J, Schotten U, Hanrath P. Verapamil prevents stretch-induced shortening of atrial effective refractory period in Langendorff-perfused rabbit heart. J Cardiovasc Electrophysiol 2001;12:85–92.PubMedCrossRefGoogle Scholar
  17. 17.
    Eijsbouts SC, Houben RP, Blaauw Y, Schotten U, Allessie MA. Synergistic action of atrial dilation and sodium channel blockade on conduction in rabbit atria. J Cardiovasc Electrophysiol 2004;15:1453–61.PubMedCrossRefGoogle Scholar
  18. 18.
    Bril A, Faivre JF, Forest MC, Cheval B, Gout B, Linee P, et al. Electrophysiological effect of BRL-32872, a novel antiarrhythmic agent with potassium and calcium channel blocking properties, in guinea pig cardiac isolated preparations. J Pharmacol Exp Ther 1995;273:1264–72.PubMedGoogle Scholar
  19. 19.
    Zarse M, Deharo JC, Mast F, Allessie MA. Importance of right and left atrial dilation and linear ablation for perpetuation of sustained atrial fibrillation. J Cardiovasc Electrophysiol 2002;13:164–71.PubMedCrossRefGoogle Scholar
  20. 20.
    Hu H, Sachs F. Stretch-activated ion channels in the heart. J Mol Cell Cardiol 1997;29:1511–23.PubMedCrossRefGoogle Scholar
  21. 21.
    Kamkin A, Kiseleva I, Wagner KD, Bohm J, Theres H, Gunther J, et al. Characterization of stretch-activated ion currents in isolated atrial myocytes from human hearts. Pflugers Arch 2003;446:339–46.PubMedGoogle Scholar
  22. 22.
    Suchyna TM, Johnson JH, Hamer K, Leykam JF, Gage DA, Clemo HF, et al. Identification of a peptide toxin from Grammostola spatulata spider venom that blocks cation-selective stretch-activated channels. J Gen Physiol 2000;115:583–98.PubMedCrossRefGoogle Scholar
  23. 23.
    Bril A, Forest MC, Cheval B, Faivre JF. Combined potassium and calcium channel antagonistic activities as a basis for neutral frequency dependent increase in action potential duration: comparison between BRL-32872 and azimilide. Cardiovasc Res 1998;37:130–40.PubMedCrossRefGoogle Scholar
  24. 24.
    Samie FH, Mandapati R, Gray RA, Watanabe Y, Zuur C, Beaumont J, et al. A mechanism of transition from ventricular fibrillation to tachycardia: effect of calcium channel blockade on the dynamics of rotating waves. Circ Res 2000;86:684–91.PubMedGoogle Scholar
  25. 25.
    Benardeau A, Fareh S, Nattel S. Effects of verapamil on atrial fibrillation and its electrophysiological determinants in dogs. Cardiovasc Res 2001;50:85–96.PubMedCrossRefGoogle Scholar
  26. 26.
    Tse HF, Wang Q, Yu CM, Ayers GM, Lau CP. Effect of verapamil on prevention of atrial fibrillation in patients implanted with an implantable atrial defibrillator. Clin Cardiol 2001;24:503–5.PubMedCrossRefGoogle Scholar
  27. 27.
    Hassan SA, Oral H, Scharf C, Chugh A, Pelosi F, Knight BP, et al. Rate-dependent effect of verapamil on atrial refractoriness. J Am Coll Cardiol 2003;41:446–51.PubMedCrossRefGoogle Scholar
  28. 28.
    Feld GK, Cha Y. Electrophysiologic effects of the new class III antiarrhythmic drug dofetilide in an experimental canine model of pacing-induced atrial fibrillation. J Cardiovasc Pharmacol Ther 1997;2:195–203.PubMedCrossRefGoogle Scholar
  29. 29.
    Pallandi RT, Lovell NH, Campbell TJ. Class III Antiarrhythmic effects of dofetilide in rabbit atrial myocardium. J Cardiovasc Pharmacol Ther 1996;1:229–34.PubMedGoogle Scholar
  30. 30.
    Kneller J, Kalifa J, Zou R, Zaitsev AV, Warren M, Berenfeld O, et al. Mechanisms of atrial fibrillation termination by pure sodium channel blockade in an ionically-realistic mathematical model. Circ Res 2005;96:e35–47.PubMedCrossRefGoogle Scholar
  31. 31.
    Wijffels MC, Dorland R, Mast F, Allessie MA. Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat: effects of cibenzoline, hydroquinidine, flecainide, and d-sotalol. Circulation 2000;102:260–7.PubMedGoogle Scholar
  32. 32.
    Youm JB, Han J, Kim N, Zhang YH, Kim E, Joo H, et al. Role of stretch-activated channels on the stretch-induced changes of rat atrial myocytes. Prog Biophys Mol Biol 2006;90:186–206.PubMedCrossRefGoogle Scholar
  33. 33.
    Li D, Benardeau A, Nattel S. Contrasting efficacy of dofetilide in differing experimental models of atrial fibrillation. Circulation 2000;102:104–12.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • J. Kalifa
    • 1
    • 2
  • M. Bernard
    • 1
  • B. Gout
    • 4
    • 6
  • A. Bril
    • 4
    • 5
    • 7
  • D. Cozma
    • 2
  • P. Laurent
    • 2
  • T. Chalvidan
    • 2
  • J. C. Deharo
    • 2
  • P. Djiane
    • 2
  • P. Cozzone
    • 1
  • J. M. Maixent
    • 3
  1. 1.Centre de Résonance Magnétique Biologique et Médicale, UMR CNRS 6612Faculté de MédecineMarseilleFrance
  2. 2.Département de CardiologieHôpital Timone AdultesMarseille Cedex 05France
  3. 3.Inserm E0324 CHU La Milétrie - BP 5772rue de la MilétriePoitiers CedexFrance
  4. 4.Laboratoire GlaxoSmithKlineUnité de Biologie CardiovasculaireSaint-GrégoireFrance
  5. 5.Bioproject Biotech4 rue du Chesnay Beauregard BP 96205Saint-Grégoire CedexFrance
  6. 6.G.S.R.ToulouseFrance
  7. 7.Institut de Researches ServierSURESNESFrance

Personalised recommendations